GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artiva Biotherapeutics Inc (NAS:ARTV) » Definitions » Forward Dividend Yield %

ARTV (Artiva Biotherapeutics) Forward Dividend Yield % : 0.00% (As of May. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Artiva Biotherapeutics Forward Dividend Yield %?

As of today (2025-05-05), the Forward Annual Dividend Yield of Artiva Biotherapeutics is 0.00%.

As of today (2025-05-05), the Trailing Annual Dividend Yield of Artiva Biotherapeutics is 0.00%.

ARTV's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.535
* Ranked among companies with meaningful Forward Dividend Yield % only.

Artiva Biotherapeutics's Dividends per Share for the three months ended in Dec. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Artiva Biotherapeutics's Forward Dividend Yield %

For the Biotechnology subindustry, Artiva Biotherapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artiva Biotherapeutics's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artiva Biotherapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Artiva Biotherapeutics's Forward Dividend Yield % falls into.


;
;

Artiva Biotherapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Artiva Biotherapeutics  (NAS:ARTV) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Artiva Biotherapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Artiva Biotherapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Artiva Biotherapeutics Business Description

Traded in Other Exchanges
N/A
Address
5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).